MedTrace Logo

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

NCT00028509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2014-02-13

No results posted yet for this study

Summary

RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects.

PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.

Conditions

  • Long-term Effects Secondary to Cancer Therapy in Children
  • Neurotoxicity

Interventions

PROCEDURE

management of therapy complications

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Patricia K. Duffner, MD · Women & Children's Hospital of Buffalo

Eligibility

Min Age
1 Year
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Primary Completion
2011-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00028509 on ClinicalTrials.gov